In this article, we look at how Mesh Bio and MultiOmic Health use AI to transform and improve the lives of metabolic syndrome patients through patient stratification and precision medicine....
This partnership will enable both companies to progress their respective R&D programmes to develop precision therapeutic and diagnostic products, transforming the lives of patients with metabolic...
The day-long conference on precision medicine and data science saw a discussion with experts on how we can collaborate and accelerate precision medicine in Asia. The development of artificial...
The grant awards the receipient $100,000 for projects focused on multiple myeloma aiming to improve treatment outcomes. Proteona, a single-cell precision medicine company, today announced awards from...
New national body established to further research insights, improve patient outcomes and create new economic opportunities for the biomedical technology industry. Precision medicine is part of...
Cross-platform evaluation study demonstrates reproducibility and high detection rate for MiRXES ID3EAL qPCR microRNA (miRNA) profiling platform when used for discovery and validation of blood-based...
Announced in late 2020, the clinical-stage biotech company, Hummingbird Bioscience and artificial intelligence (AI) and precision medicine technology company Tempus partner to help drive clinical...
D3 Bio, a global biotechnology company announced the launch of a USD 200 million Series A financing by a number of investors to support its portfolio in the development of precision medicine to...
Researchers from the Duke-NUS Medical School in Singapore have shed light from their study on the role of long non-coding RNAs in the development of pancreatic cancer, bringing potential to new...
Dornier MedTech launches UroX, a community that connects professionals from various disciplines to cultivate innovation and solve the most pressing challenges in urology. Globally, over 900 million...
Collaborative research from scientists across China have developed a comprehensive proteomic analysis on Chinese patients with lung adenocarcinoma (LUAD). Lung cancer is one of the most commonly...
Leaders from global institutions, academia, healthcare and government organisations come together at a Seminar on Precision Medicine organised by BC Platforms. They discuss about the challenges,...
